Istodax & Thrombocytopenia

14.8%

of users reported Thrombocytopenia

62.8%

also reported Severe reaction

55.6%

are women

Severe reaction

62.8%

Hospitalization

18.1%

Death

12.8%

Life-threatening condition

6.4%

Istodax: general information

30 - 39 years

1.6%

40 - 49 years

1.6%

50 - 59 years

10.7%

60 - 69 years

22.0%

70 - 79 years

39.9%

80 - 89 years

24.1%